文献速递胃肠动力与功能性疾病消化内镜

评估创新内镜技术:经口内镜下肌切开术治疗贲门失弛缓症的成本效益

Valuing innovative endoscopic techniques: per-oral endoscopic myotomy for the management of achalasia.
PubMed 文献 · Gastrointest Endosc · 2018-04-21

研究构建决策分析模型,从支付方角度比较经口内镜下肌切开术(POEM)与腹腔镜Heller肌切开术联合Dor胃底折叠术(LHM)治疗贲门失弛缓症1年时间内的成本效益。结果显示两者1年效果相似(0.91 QALY),POEM最大成本效益报销额度为8033.37至8223.14美元。

要点

  • POEM与LHM在1年随访时效果相似,均为0.91 QALY。
  • POEM最大成本效益报销额度为8033.37至8223.14美元(含全部专业和设施费用)。
  • 若POEM相比LHM节省至少10%成本(成本最小化分析)或至少44%成本(成本效益分析,WTP=100000美元/QALY),术后GERD发生率不影响POEM偏好。

核心结论

  • POEM是一种创新且可能具有颠覆性的内镜技术,在当前报销水平下,与既定手术标准相比,具有更高的成本效益价值和相似的结果。

研究设计与样本

  • 构建决策分析模型,从支付方角度比较POEM与LHM治疗贲门失弛缓症,时间范围为1年;报销数据来自2017年Medicare数据;应答率基于 validated Eckardt评分中有临床意义的改善;健康效用值基于标准博弈技术先前推导的数据;使用当代支付意愿(WTP)水平通过阈值分析估算POEM最大报销额度。

主要发现

  • POEM与LHM在1年随访时效果相似,均为0.91 QALY。
  • POEM最大成本效益报销额度为8033.37至8223.14美元,包括所有专业和设施费用。
  • 该额度与当代先进内镜手术总报销10至15个相对价值单位相比具有优势。
  • 假设POEM相比LHM节省至少10%成本(成本最小化分析)或至少44%成本(成本效益分析,WTP=100000美元/QALY),术后GERD发生率不影响POEM相比LHM的偏好。
  • 仅当两种手术报销相似时LHM才被优先选择,且这些发现主要由较低的术后GERD发生率驱动。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Unclear reimbursement for new and innovative endoscopic procedures can limit adoption in clinical practice despite effectiveness in clinical trials. The aim of this study was to determine maximum cost-effective reimbursement for per-oral endoscopic myotomy (POEM) in treating achalasia. METHODS: We constructed a decision-analytic model assessing POEM versus laparoscopic Heller myotomy with Dor fundoplication (LHM) in managing achalasia from a payer perspective over a 1-year time horizon. Reimbursement data were derived from 2017 Medicare data. Responder rates were based on clinically meaningful improvement in validated Eckardt scores. Validated health utility values were assigned to terminal health states based on data previously derived with a standard gamble technique. Contemporary willingness-to-pay (WTP) levels per quality-adjusted life year (QALY) were used to estimate maximum reimbursement for POEM using threshold analysis. RESULTS: Effectiveness of POEM and LHM was similar at 1 year of follow-up (0.91 QALY). Maximum cost-effective reimbursement for POEM was $8033.37 to $8223.14, including all professional and facility fees. This compares favorably with contemporary total reimbursement of 10 to 15 total relative value units for advanced endoscopic procedures. Rates of postprocedural GERD did not affect the preference for POEM compared with LHM, assuming at least 10% cost savings with POEM compared with LHM in cost-minimization analysis, or at least 44% cost savings in cost-effectiveness analysis (WTP = $100,000/QALY). LHM was only preferred over POEM if both procedures were reimbursed similarly, and these findings were primarily driven by lower rates of postprocedural GERD. The rate of conversion to open laparotomy due to perforation or bleeding was infrequent in published clinical practice experience, thus did not significantly affect reimbursement. DISCUSSION: POEM is an example of an innovative and potentially disruptive endoscopic technique offering greater cost-effective value and similar outcomes to the established surgical standard at contemporary reimbursement levels.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Shah ED, Chang AC, Law R, et al. Valuing innovative endoscopic techniques: per-oral endoscopic myotomy for the management of achalasia. Gastrointest Endosc. 2018. PMID: 29684386. doi:10.1016/j.gie.2018.04.2341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。